#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cryoglobulinaemia Epilepsy with myoclonic-atonic seizures Uveitis Mantle cell lymphoma stage IV Systemic scleroderma Epidermolysis bullosa Monogenic diabetes Von Willebrand's disease Diffuse large B-cell lymphoma Hypertriglyceridaemia Hepatic cirrhosis Chorioretinitis Polycythaemia vera Renal cancer metastatic Renal disorder More trials…

    Learn about Rare Diseases

    Haemophagocytic lymphohistiocytosis – Diagnostics Idiopathic pulmonary fibrosis Combined immunodeficiency – Basic Information Glomerulonephritis membranoproliferative – Life with Disease Testicular leiomyosarcoma – Treatment Hypereosinophilic syndrome – Treatment Glomerulonephritis membranous – Trials in Disease Gaucher’s disease type I – Basic Information Hereditary optic atrophy Pelizaeus-Merzbacher disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ribociclib Xanthum Gum Siponimod Kd050 Buprenorphine Aavanc80-5'Hotof Cat Epithelium Extract Raxtozinameran VORMATRIGINE Arachis Hypogaea (762) Reboxetine Nacystelyn Pimavanserin Tartrate Ecoo6A Macrogol 4000 Lenalidomide Ly3537982 Sabatolimab Diroximel Fumarate Azd5863 More therapies…

    Learn about Your Condition

    Portal hypertension Erectile dysfunction K-ras gene mutation Liver transplant rejection Embolic stroke Pseudomonas infection Diabetic retinal oedema Encephalitis autoimmune Bone hypertrophy Obliterative bronchiolitis Carotid artery stenosis KBG syndrome Hypertrophic scar Von Willebrand's disease Ureteric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Koranyi National Institute For Pulmonology

Koranyi National Institute For Pulmonology

Koranyi Frigyes Ut 1, Budapest, 1121, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Bulgaria Denmark France Germany Greece Hungary +4

  • Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium Denmark France Germany Greece Hungary +4

  • Study on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage I
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Datopotamab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study on JDQ443 and Docetaxel for Patients with Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    • Docetaxel
    Finland Greece Hungary Iceland Italy Portugal +3

  • Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Pembrolizumab
    Austria Belgium France Germany Greece Hungary +7

  • Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Argipressin
    • Mannitol
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Austria Czechia Germany Greece Hungary Latvia +3

  • Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Patritumab Deruxtecan
    • Carboplatin
    • Paclitaxel
    Greece Hungary Italy Poland Spain

  • Study of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Carboplatin
    • Durvalumab
    • Etoposide
    Austria Belgium Denmark France Germany Greece +7

  • Effectiveness and Safety of Rezafungin in Adults with Chronic Pulmonary Aspergillosis Who Have Limited Treatment Options

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bronchopulmonary aspergillosis
    Investigated Drugs:
    • Rezafungin Acetate
    Austria Belgium France Germany Hungary Italy +2
Previous Page
1 2 3 4 5 6 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!